A Facile Approach for the Synthesis of Highly Pure Immunomodulator Drugs-Leflunomide and Teriflunomide: A Robust Strategy to Control Impurities
A facile synthesis of immunomodulator drugs, Leflunomide (10) and its active metabolite, Teriflunomide (1) is described. The synthesis is sequential and comprises N-acylation of 4-trifluoromethyl aniline (9) with 5-methylisoxazole-4-carboxylic acid chloride (8) in dimethoxyethane as a solvent to yield leflunomide (10) with an overall yield of 68% and 99.8% purity by HPLC. Sodium hydroxide mediated isoxazole ring scission of leflunomide (10) in aqueous methanol furnished teriflunomide with 81% yield and 99.9% purity by HPLC. The work further describes raw material and process attributes which are critical to control the process related, degradation and carryover impurities in both 10 and 1.
Full Text Attachment